Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Angocin
- Development stage
- Unknown
- Lead developer
- Repha
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Angocin is a herbal phytotherapy product developed and marketed by Max Zeller Söhne AG. It consists of a fixed-dose combination of nasturtium herb powder (*Tropaeoli herbae pulvis*) and horseradish root powder (*Armoraciae radicis pulvis*). The therapeutic activity is derived from glucosinolates which, upon ingestion, are converted into isothiocyanates (mustard oils). These compounds exhibit broad-spectrum antibacterial, antiviral, and anti-inflammatory properties. Angocin is approved in Switzerland as an over-the-counter (OTC) medication for the treatment of acute respiratory infections, including sinusitis and bronchitis, as well as for the management of uncomplicated urinary tract infections such as cystitis.
- Brand names
- Angocin
- Other names
- nasturtium herb powder + horseradish root powderTropaeoli herbae pulvis + Armoraciae radicis pulvis
Beyond the preview
Go deeper on Angocin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angocin.